BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18481230)

  • 1. Bronchodilator response in residual volume in irreversible airway obstruction.
    Balestra AM; Bingisser RB; Chhajed PN; Tamm M; Leuppi JD
    Swiss Med Wkly; 2008 May; 138(17-18):251-5. PubMed ID: 18481230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium and simplified detection of dynamic hyperinflation.
    Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
    Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual Volume and Total Lung Capacity to Assess Reversibility in Obstructive Lung Disease.
    McCartney CT; Weis MN; Ruppel GL; Nayak RP
    Respir Care; 2016 Nov; 61(11):1505-1512. PubMed ID: 27555617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic role of residual volume in paediatric patients with chronic symptoms of the lower airways.
    Walamies MA
    Clin Physiol; 1998 Jan; 18(1):49-54. PubMed ID: 9545620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of bronchodilation in the clinical pulmonary function laboratory. Role of changes in static lung volumes.
    Ramsdell JW; Tisi GM
    Chest; 1979 Dec; 76(6):622-8. PubMed ID: 510000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD - A randomised, multicentre, crossover trial.
    Watz H; Mailänder C; May C; Baier M; Kirsten AM
    Pulm Pharmacol Ther; 2017 Feb; 42():13-20. PubMed ID: 27940287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator Responses in Respiratory Impedance, Hyperinflation and Gas Trapping in COPD.
    Milne S; Hammans C; Watson S; Farah CS; Thamrin C; King GG
    COPD; 2018; 15(4):341-349. PubMed ID: 29799289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compressive air trapping in asthma: effects of age, sex, and severity.
    Sorkness RL; Kienert C; O'Brien MJ; Fain SB; Jarjour NN
    J Appl Physiol (1985); 2019 May; 126(5):1265-1271. PubMed ID: 30844338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 15. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstruction.
    Ozkaya S; Dirican A; Kaya SO; Karanfil RC; Bayrak MG; Bostancı O; Ece F
    Int J Chron Obstruct Pulmon Dis; 2014; 9():453-6. PubMed ID: 24833899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of lung volume measurements by plethysmography in the follow-up of asthma in children].
    Labbé G; Merlin E; Kauffman C; Fauquert JL; Héraud MC; Labbé A
    Rev Mal Respir; 2010; 27(1):42-8. PubMed ID: 20146951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma.
    Taube C; Kanniess F; Grönke L; Richter K; Mücke M; Paasch K; Eichler G; Jörres RA; Magnussen H
    Respir Med; 2003 May; 97(5):568-77. PubMed ID: 12735677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.
    Deesomchok A; Webb KA; Forkert L; Lam YM; Ofir D; Jensen D; O'Donnell DE
    COPD; 2010 Dec; 7(6):428-37. PubMed ID: 21166631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.